235 related articles for article (PubMed ID: 15937959)
21. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
22. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
[TBL] [Abstract][Full Text] [Related]
23. Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogeneously staining region.
Arcand SL; Mes-Masson AM; Provencher D; Hudson TJ; Tonin PN
Mol Carcinog; 2004 Sep; 41(1):17-38. PubMed ID: 15352123
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.
Wojnarowicz PM; Provencher DM; Mes-Masson AM; Tonin PN
Int J Oncol; 2012 Jun; 40(6):1865-80. PubMed ID: 22344671
[TBL] [Abstract][Full Text] [Related]
25. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.
Kalikin LM; Frank TS; Svoboda-Newman SM; Wetzel JC; Cooney KA; Petty EM
Oncogene; 1997 Apr; 14(16):1991-4. PubMed ID: 9150366
[TBL] [Abstract][Full Text] [Related]
26. Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors.
Abdollahi A; Roberts D; Godwin AK; Schultz DC; Sonoda G; Testa JR; Hamilton TC
Oncogene; 1997 Apr; 14(16):1973-9. PubMed ID: 9150364
[TBL] [Abstract][Full Text] [Related]
27. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
Zhang Z; Gerhard DS; Nguyen L; Li J; Traugott A; Huettner PC; Rader JS
Genes Chromosomes Cancer; 2005 May; 43(1):95-103. PubMed ID: 15672406
[TBL] [Abstract][Full Text] [Related]
28. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
29. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.
Shridhar V; Sen A; Chien J; Staub J; Avula R; Kovats S; Lee J; Lillie J; Smith DI
Cancer Res; 2002 Jan; 62(1):262-70. PubMed ID: 11782386
[TBL] [Abstract][Full Text] [Related]
30. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
[TBL] [Abstract][Full Text] [Related]
31. Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer.
Liu Y; Emilion G; Mungall AJ; Dunham I; Beck S; Le Meuth-Metzinger VG; Shelling AN; Charnock FM; Ganesan TS
Oncogene; 2002 Jan; 21(3):387-99. PubMed ID: 11821951
[TBL] [Abstract][Full Text] [Related]
32. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
[TBL] [Abstract][Full Text] [Related]
33. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
35. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
36. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
Sellar GC; Watt KP; Rabiasz GJ; Stronach EA; Li L; Miller EP; Massie CE; Miller J; Contreras-Moreira B; Scott D; Brown I; Williams AR; Bates PA; Smyth JF; Gabra H
Nat Genet; 2003 Jul; 34(3):337-43. PubMed ID: 12819783
[TBL] [Abstract][Full Text] [Related]
37. Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor.
Tamimi Y; Ziebart K; Desaulniers N; Dietrich K; Grundy P
Genes Chromosomes Cancer; 2007 Apr; 46(4):327-35. PubMed ID: 17243164
[TBL] [Abstract][Full Text] [Related]
38. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
[TBL] [Abstract][Full Text] [Related]
39. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
[TBL] [Abstract][Full Text] [Related]
40. Identification of candidate liver tumor suppressor genes from human 11p11.2 by transcription mapping of microcell hybrid cell lines.
Jahn JE; Ricketts SL; Coleman WB
Int J Oncol; 2003 Jun; 22(6):1303-10. PubMed ID: 12738998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
